A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.
On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...
Criswell and Dr. Abby Fleish, a pediatric endocrinologist at MaineHealth, are studying whether an older cholesterol-lowering ...
Whether you're a morning person or not, many of us struggle to start the day without a caffeine hit to kick start our day.
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...
Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...
Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...
The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to ...
The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback